摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<2-<<(4-methyl-5-imidazolyl)methyl>thio>ethyl>-4-hydroxybenzamidine | 57785-50-9

中文名称
——
中文别名
——
英文名称
N-<2-<<(4-methyl-5-imidazolyl)methyl>thio>ethyl>-4-hydroxybenzamidine
英文别名
4-hydroxy-N-[2-(5-methyl-1(3)H-imidazol-4-ylmethylsulfanyl)-ethyl]-benzamidine;N-<2-(5-Methyl-4-imidazolylmethylthio)-ethyl>-4-hydroxybenzamidin;N-[2-(5-Methyl-4-imidazolylmethylthio)ethyl]-4-hydroxybenzamidine;4-hydroxy-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]benzenecarboximidamide
N-<2-<<(4-methyl-5-imidazolyl)methyl>thio>ethyl>-4-hydroxybenzamidine化学式
CAS
57785-50-9
化学式
C14H18N4OS
mdl
——
分子量
290.389
InChiKey
YQWSPFUBXXZRMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    113
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-<2-<<(4-methyl-5-imidazolyl)methyl>thio>ethyl>-4-hydroxybenzamidinetetraphosphorus decasulfide吡啶 为溶剂, 反应 0.75h, 生成 N-[2-(5-Methyl-4-imidazolylmethylthio)ethyl]-4-mercaptobenzamidine
    参考文献:
    名称:
    Pharmacologically active compounds
    摘要:
    这些化合物是烷基胍基的N-(杂环甲基硫代烷基)衍生物,C-烷基和C-芳基酰胺和S-烷基异硫脲。这些化合物可能还具有N'-低烷基或N'-(杂环甲基硫代烷基)取代基。该发明的三种化合物是S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲,N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胍和N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]N''-甲基胍。该发明的化合物是组胺H.sub.2 -拮抗剂。
    公开号:
    US04107319A1
  • 作为产物:
    参考文献:
    名称:
    Zwitterionic analogs of cimetidine as H2 receptor antagonists
    摘要:
    A series of analogues of the H2 receptor histamine antagonist cimetidine have been synthesized in which the dipolar cyanoguanidine group has been replaced by a number of zwitterionic moieties. Although none of the compounds is more effective than cimetidine in blocking histamine-stimulated tachycardia on the isolated guinea pig atrium, the activities of most of the compounds possessing rigid dipoles can be accounted for on the basis of dipole orientation relative to the common side chain and by considering the active species in each case to be the zwitterion. These findings are in general agreement with those found for analogues having conjugated groups as dipoles.
    DOI:
    10.1021/jm00390a006
点击查看最新优质反应信息

文献信息

  • Heterocyclic-methylthioalkyl-guanidines
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04170652A1
    公开(公告)日:1979-10-09
    The compounds are N-(heterocyclomethylthioalkyl)derivatives of alkylguanidines, C-alkyl and C-aryl amidines and S-alkylisothioureas. The compounds may also have N'-lower alkyl or N'-(heterocyclomethylthioalkyl)substituents. Three compounds of the invention are S-methyl-N-[2-(5-methyl-4-imidazolylmethylthio)ethyl]isothiourea, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]acetamidine, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]N"-methylguanidine. The compounds of this invention are histamine H.sub.2 -antagonists.
    这些化合物是烷基胍基的N-(杂环甲基硫代烷基)衍生物、C-烷基和C-芳基酰胺和S-烷基异硫脲。这些化合物也可能具有N'-低烷基或N'-(杂环甲基硫代烷基)取代基。该发明的三种化合物是S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲、N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胺和N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]N''-甲基胍。该发明的化合物是组胺H.sub.2 -拮抗剂。
  • Isothiourea compounds and pharmacological use
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04191769A1
    公开(公告)日:1980-03-04
    The compounds are N-(heterocyclomethylthioalkyl) derivatives of alkylguanidines, C-alkyl and C-aryl amidines and S-alkylisothioureas. The compounds may also have N'-lower alkyl or N'(heterocyclomethylthioalkyl) substituents. Three compounds of the invention are S-methyl-N-[2-(5-methyl-4-imidazolylmethylthio)ethyl]isothiourea, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]acetamidine, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]N"-methylguanidine. The compounds of this invention are histamine H.sub.2 -antagonists.
    这些化合物是烷基胍基衍生物的N-(杂环甲基硫代烷基)衍生物,C-烷基和C-芳基酰胺基和S-烷基异硫脲。这些化合物还可能具有N'-低烷基或N'(杂环甲基硫代烷基)取代基。该发明的三种化合物是S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲、N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胺基和N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]N''-甲基胍。该发明的这些化合物是组胺H.sub.2 -拮抗剂。
  • Amidino compounds
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04036971A1
    公开(公告)日:1977-07-19
    The compounds are N-(heterocyclomethylthioalkyl)derivatives of alkylguanidines, C-alkyl and C-aryl amidines and S-alkyl-isothioureas. The compounds may also have N'-lower alkyl or N'-(heterocyclomethylthioalkyl)substituents. Three compounds of the invention are S-methyl-N-[2-(5-methyl-4-imidazolylmethylthio)ethyl]isothiourea, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]acetamidine, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]N"-methylguanidine. The compounds of this invention are histamine H.sub.2 -antagonists.
    这些化合物是烷基胍基的N-(杂环甲基硫代烷基)衍生物、C-烷基和C-芳基酰胺和S-烷基异硫脲。这些化合物也可能具有N'-低烷基或N'-(杂环甲基硫代烷基)取代基。本发明的三种化合物是S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲、N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胺和N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]N''-甲基胍。这些化合物是组胺H.sub.2 -拮抗剂。
  • Pharmacologically active compounds
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04107319A1
    公开(公告)日:1978-08-15
    The compounds are N-(heterocyclomethylthioalkyl)derivatives of alkylguanidines, C-alkyl and C-aryl amidines and S-alkylisothioureas. The compounds may also have N'-lower alkyl or N'-(heterocyclomethylthioalkyl)substituents. Three compounds of the invention are S-methyl-N-[2-(5-methyl-4-imidazolylmethylthio)ethyl]isothiourea, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]acetamidine, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]N"-methylguanidine. The compounds of this invention are histamine H.sub.2 -antagonists.
    这些化合物是烷基胍基的N-(杂环甲基硫代烷基)衍生物,C-烷基和C-芳基酰胺和S-烷基异硫脲。这些化合物可能还具有N'-低烷基或N'-(杂环甲基硫代烷基)取代基。该发明的三种化合物是S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲,N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胍和N,N'-双-[2-(5-甲基-4-咪唑甲基硫基)乙基]N''-甲基胍。该发明的化合物是组胺H.sub.2 -拮抗剂。
  • Heterocyclic-methylthioalkyl-amidines
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04118496A1
    公开(公告)日:1978-10-03
    The compounds are N-(heterocyclomethylthioalkyl)derivatives of alkylguanidines, C-alkyl and C-aryl amidines and S-alkyl-isothioureas. The compounds may also have N'-lower alkyl or N'-(heterocyclomethylthioalkyl)substituents. Three compounds of the invention are S-methyl-N-[2-(5-methyl-4-imidazolyl-methylthio)ethyl]isothiourea, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]acetamidine, N,N'-bis-[2-(5-methyl-4-imidazolylmethylthio)ethyl]N"-methylguanidine. The compounds of this invention are histamine H.sub.2 -antagonists.
    这些化合物是烷基胍基的N-(杂环甲基硫代烷基)衍生物,C-烷基和C-芳基酰胺和S-烷基异硫脲。这些化合物还可以具有N'-较低烷基或N'-(杂环甲基硫代烷基)取代基。本发明的三种化合物为S-甲基-N-[2-(5-甲基-4-咪唑甲基硫基)乙基]异硫脲,N,N'-双[2-(5-甲基-4-咪唑甲基硫基)乙基]乙酰胺和N,N'-双[2-(5-甲基-4-咪唑甲基硫基)乙基]N"-甲基胍。本发明的化合物是组胺H.sub.2 -拮抗剂。
查看更多